Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 1 (2004), Issue 3 (November)

1. Current standards of surgery for pancreatic cancer.
   Br J Surg, 91(11): 1410-27. [Abstract] [Full-text]
2. Coexistence of annular pancreas with carcinoma in the dorsal part of pancreas divisum: diagnostic value of magnetic resonance cholangiopancreatography.
   Abdom Imaging, 29(6): 703-6. [Abstract] [Full-text]
3. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer.
   Surgery, 136(5): 1003-11. [Abstract] [Full-text]
4. Pancreatic cancer and thromboembolic disease.
   Lancet Oncol, 5(11): 655-63. [Abstract] [Full-text]
5. Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations.
   J Vasc Interv Radiol, 15(11): 1251-6. [Abstract] [Full-text]
6. Genetics of hereditary pancreatic carcinoma.
   Gastroenterol Clin North Am, 33(4): 919-34, ix. [Abstract] [Full-text]
7. Identification of high-risk pancreatic cancer-prone families.
   Gastroenterol Clin North Am, 33(4): 907-18. [Abstract] [Full-text]
8. Molecular diagnosis of solid and cystic lesions of the pancreas.
   Gastroenterol Clin North Am, 33(4): 891-906. [Abstract] [Full-text]
9. Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1.
   J Clin Endocrinol Metab, 89(11): 5328-36. [Abstract] [Full-text]
10. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy.
    J Gastrointest Surg, 8(7): 775-84; discussion 784. [Abstract] [Full-text]
11. Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain.
    Eur J Pain, 8(6): 539-45. [Abstract] [Full-text]
12. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis.
    Cancer, 101(10): 2351-62. [Abstract] [Full-text]
13. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
    Cancer, 101(10): 2341-50. [Abstract] [Full-text]
14. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Cancer, 101(10): 2309-17. [Abstract] [Full-text]
15. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma.
    Clin Cancer Res, 10(21): 7427-37. [Abstract] [Full-text]
16. Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer.
    Clin Cancer Res, 10(21): 7290-6. [Abstract] [Full-text]
17. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.
    Oncogene, 23(53): 8705-10. [Abstract] [Full-text]
18. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
    Oncogene, 23(53): 8571-80. [Abstract] [Full-text]
19. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples.
    Gut, 53(12): 1860-5. [Abstract] [Full-text]
20. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer.
    J Clin Oncol, 22(22): 4456-62. [Abstract] [Full-text]
21. Choriocarcinoma involving the pancreas as first manifestation of a metastatic regressing mixed testicular germ cell tumor.
    Mod Pathol, 17(12): 1573-80. [Abstract] [Full-text]
22. Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.
    Scand J Gastroenterol, 39(11): 1159-65. [Abstract] [Full-text]
23. Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.
    Endocrinology, 145(12): 5774-85. [Abstract] [Full-text]
24. Pancreatic cancer: management and survival.
    ANZ J Surg, 74(11): 941-4. [Abstract] [Full-text]
25. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4.
    Cancer Res, 64(22): 8420-7. [Abstract] [Full-text]
26. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer.
    Cancer Res, 64(22): 8405-10. [Abstract] [Full-text]
27. Successful surgical treatment of a primary liver gastrinoma during pregnancy: a case report.
    Am J Obstet Gynecol, 191(5): 1716-8. [Abstract] [Full-text]
28. Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
    Tissue Antigens, 64(6): 696-702. [Abstract] [Full-text]
29. The fine-needle aspiration biopsy cytology of pancreatoblastoma.
    Diagn Cytopathol, 31(6): 402-6. [Abstract] [Full-text]
30. Primary pancreatic lymphomas: a cytopathologic analysis of a rare malignancy.
    Cancer, 102(5): 315-21. [Abstract] [Full-text]
31. Interferon-gamma polymorphisms correlate with duration of survival in pancreatic cancer.
    Hum Immunol, 65(11): 1405-8. [Abstract] [Full-text]
32. Pancreatic neoplasms.
    Gastrointest Endosc Clin N Am, 15(1): 117-42, x. [Abstract] [Full-text]
33. A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer.
    Am J Gastroenterol, 99(11): 2223-34. [Abstract] [Full-text]
34. Peripheral nerve endoneurial microangiopathy and necrosis in rats with insulinoma.
    Acta Neuropathol (Berl), 108(6): 503-14. [Abstract] [Full-text]
35. Novel strategic therapeutic approaches for prevention of local recurrence of pancreatic cancer after resection: trans-tissue, sustained local drug-delivery systems.
    J Control Release, 100(3): 317-30. [Abstract] [Full-text]
36. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
    J Clin Oncol, 22(23): 4762-71. [Abstract] [Full-text]
37. Copy number of chromosome 17 but not HER2 amplification predicts clinical outcome of patients with pancreatic ductal adenocarcinoma.
    J Clin Oncol, 22(23): 4737-45. [Abstract] [Full-text]
38. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
    Clin Cancer Res, 10(22): 7775-84. [Abstract] [Full-text]
39. Meta-analysis: the detection of pancreatic malignancy with positron emission tomography.
    Aliment Pharmacol Ther, 20(10): 1063-70. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.